AAPL   318.72 (+0.15%)
MSFT   182.09 (+0.38%)
FB   225.04 (-0.19%)
GOOGL   1,420.98 (+0.19%)
AMZN   2,407.50 (+0.27%)
NVDA   344.09 (+1.36%)
CGC   17.58 (-19.06%)
BABA   198.81 (-0.35%)
TSLA   819.16 (+1.66%)
AMD   52.28 (+1.04%)
T   30.48 (-1.87%)
DIS   115.19 (-1.34%)
NFLX   413.35 (-0.02%)
BAC   24.38 (-1.93%)
AAPL   318.72 (+0.15%)
MSFT   182.09 (+0.38%)
FB   225.04 (-0.19%)
GOOGL   1,420.98 (+0.19%)
AMZN   2,407.50 (+0.27%)
NVDA   344.09 (+1.36%)
CGC   17.58 (-19.06%)
BABA   198.81 (-0.35%)
TSLA   819.16 (+1.66%)
AMD   52.28 (+1.04%)
T   30.48 (-1.87%)
DIS   115.19 (-1.34%)
NFLX   413.35 (-0.02%)
BAC   24.38 (-1.93%)
AAPL   318.72 (+0.15%)
MSFT   182.09 (+0.38%)
FB   225.04 (-0.19%)
GOOGL   1,420.98 (+0.19%)
AMZN   2,407.50 (+0.27%)
NVDA   344.09 (+1.36%)
CGC   17.58 (-19.06%)
BABA   198.81 (-0.35%)
TSLA   819.16 (+1.66%)
AMD   52.28 (+1.04%)
T   30.48 (-1.87%)
DIS   115.19 (-1.34%)
NFLX   413.35 (-0.02%)
BAC   24.38 (-1.93%)
AAPL   318.72 (+0.15%)
MSFT   182.09 (+0.38%)
FB   225.04 (-0.19%)
GOOGL   1,420.98 (+0.19%)
AMZN   2,407.50 (+0.27%)
NVDA   344.09 (+1.36%)
CGC   17.58 (-19.06%)
BABA   198.81 (-0.35%)
TSLA   819.16 (+1.66%)
AMD   52.28 (+1.04%)
T   30.48 (-1.87%)
DIS   115.19 (-1.34%)
NFLX   413.35 (-0.02%)
BAC   24.38 (-1.93%)
Log in

OTCMKTS:TKPYYTakeda Pharmaceutical Stock Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume755,707 shs
Average Volume5.90 million shs
Market Capitalization$24.14 billion
P/E Ratio12.11
Dividend Yield3.48%
Beta0.42
Takeda Pharmaceutical Company Limited engages in the research and development, manufacture, marketing, and sale of pharmaceutical products worldwide. The company operates in three segments: Prescription Drug, Consumer Healthcare, and Other. It offers prescription, OTC, and quasi-drugs; and reagents in various therapeutic areas, including oncology, gastroenterology, central nervous system (CNS), vaccines, and others. The company is also involved in clinical diagnostics, chemical products, and other businesses. Takeda Pharmaceutical Company Limited has a research collaboration with Shattuck Labs, Inc. to develop checkpoint fusion proteins that have the potential to become immunotherapies; and a collaboration alliance with Stanford University. It also has collaboration agreement with Samsung Bioepis Co., Ltd. to co-develop various biologic therapies; AstraZeneca PLC to develop and commercialize MEDI1341, an alpha synuclein antibody for the treatment of Parkinson's disease; Noile-Immune Biotech Inc. for the research and development of cancer immunotherapy; HitGen Ltd for the DNA-encoded library based drug discovery research; Montreal Neurological Institute to discover and develop treatments for amyotrophic lateral sclerosis; Denali Therapeutics to develop and commercialize therapeutic product candidates for neurodegenerative diseases; Fujifilm to develop regenerative medicine product for heart patients; Wave Life Sciences Ltd. to discover, develop, and commercialize nucleic acid therapies for disorders of CNS, as well as drugs for neglected diseases initiative; and Molecular Templates to develop CD38-targeted engineered toxin bodies. In addition, the company has a licensing agreement with Fimecs, Inc. for the development of novel immuno-oncology therapies; and a clinical collaboration with Nektar Therapeutics to evaluate the combination of NKTR-214 and TAK-659. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Osaka, Japan.
Read More
Takeda Pharmaceutical logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.12 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TKPYY
CUSIPN/A
CIKN/A
Phone816-6204-2111

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$15.99 billion
Book Value$11.62 per share

Profitability

Net Income$1.68 billion

Miscellaneous

EmployeesN/A
Outstanding Shares1,562,360,000
Market Cap$24.14 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive TKPYY News and Ratings via Email

Sign-up to receive the latest news and ratings for TKPYY and its competitors with MarketBeat's FREE daily newsletter.

Takeda Pharmaceutical (OTCMKTS:TKPYY) Frequently Asked Questions

Has Takeda Pharmaceutical been receiving favorable news coverage?

Media stories about TKPYY stock have been trending positive this week, according to InfoTrie Sentiment. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Takeda Pharmaceutical earned a media sentiment score of 2.7 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 3.0 out of 10, meaning that recent news coverage is unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutTakeda Pharmaceutical.

Who are some of Takeda Pharmaceutical's key competitors?

Who are Takeda Pharmaceutical's key executives?

Takeda Pharmaceutical's management team includes the following people:
  • Mr. Christophe Weber, Pres, CEO & Representative Director (Age 52)
  • Mr. Andrew S. Plump M.D., Ph.D., Chief Medical & Scientific Officer and Director
  • Dr. Seigo Izumo M.D., Chair of Management Board
  • Mr. Costa Saroukos, Chief Financial Officer
  • Mr. Haruhiko Hirate, Member of Management Board and Corp. Communications & Public Affairs Officer

What is Takeda Pharmaceutical's stock symbol?

Takeda Pharmaceutical trades on the OTCMKTS under the ticker symbol "TKPYY."

How do I buy shares of Takeda Pharmaceutical?

Shares of TKPYY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

How big of a company is Takeda Pharmaceutical?

Takeda Pharmaceutical has a market capitalization of $0.00 and generates $15.99 billion in revenue each year.

What is Takeda Pharmaceutical's official website?

The official website for Takeda Pharmaceutical is www.takeda.com.

How can I contact Takeda Pharmaceutical?

Takeda Pharmaceutical's mailing address is 1-1 Doshomachi 4-chome Chuo-ku, Osaka M0, 540-8645. The company can be reached via phone at 816-6204-2111.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.